GlobeNewsWire
16 Sept 2026, 19:42 UTC · 1h ago
Verdict
Headline leans bearish. We score CAPR −0.90 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−0.90strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
The FDA extended the PDUFA target action date for deramiocel from August 22, 2026, to November 22, 2026.
Priced inannounced Aug 24
So whatThe 3-month delay pushes the potential commercialization catalyst into Q4 2026, increasing the risk of a cash runway shortfall.
More negative than 86% of claims this week
Capricor submitted a major amendment to the FDA requesting to pivot toward a refined indication focused solely on upper limb function.
Continue reading
5 related stories
More negative than 91% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Priced inannounced Aug 24
So whatA narrower indication typically reduces the total addressable market (TAM) and could lower peak sales estimates.
More negative than 72% of claims this week
A shareholder class action lawsuit is ongoing with a September 28, 2026, deadline for lead plaintiff appointment.
Newpress release dated Sept 16
So whatLegal liabilities from the Dec 17, 2025, to July 26, 2026, window could result in cash settlements that impact the balance sheet.
More negative than 62% of claims this week
Which stocks this story touches
More negative than 91% of ticker scores this week
The company is facing a securities class action lawsuit and an FDA delay in the review of its lead cell therapy.
More negative than 83% of ticker scores this week
The company is mentioned as the subject of a legal solicitation following a stock plunge due to allegedly misleading financial statements.
More negative than 83% of ticker scores this week
The company is mentioned as the subject of a legal solicitation following a stock plunge due to allegedly misleading financial statements.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
1h ago
+0.0%
Price flat so far
$8.56 vs $8.56 close before publication (Sep 15) · not market-adjusted
CAPR chart →
